These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-000537-11 An open label, multi-center study on the efficacy and safety of IgPro10 in patients with chronic immune thrombocytopenic purpura ITP 2006-03-28 due-trials
Listed as ongoing, but also has a completion date and reported results 2004-001186-17 Human pasteurized C1 esterase inhibitor concentrate (CE1145) in subjects with congenital C1-INH deficiency and acute abdominal or facial HAE attacks 2008-05-16 bad-data
Reported results 2004-004868-69 Study of Safety and Efficacy of Antihemophilic Factor / von Willebrand Factor Complex (Humate-P®) Using Individualized Dosing in Pediatric and Adult Surgical Subjects with von Willebrand’s Disease 2006-01-31 due-trials
Reported results 2005-000382-19 Efficacy and tolerance of BERIPLEX® P/N in subjects with acquired deficiency of coagulation factors II, VII, IX and X due to oral anticoagulation 2007-02-28 due-trials
Ongoing, reported early 2005-000651-14 A Single Site, Open-Label Study to Evaluate the Immunogenicity and Safety of Influenza Vaccine, CSL Limited in Healthy 'Adults' aged >18 to <60 years and in Healthy 'Older Adults' aged >60 years for t... not-yet-due
No trial status on register 2005-003139-38 Open-label extension study of CE1145 (Human pasteurized C1 esterase inhibitor concentrate) in subjects with congenital C1-INH deficiency and acute HAE attacks bad-data
Ongoing, reported early 2005-003331-44 A Randomized, Observer-Blind, Single-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of Enzira 2005/2006 compared to Mutagrip 2005/2006 in Healthy '[email protected] aged >18 to <60 years a... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2005-003459-12 A Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase III/IV Study to compare the Efficacy and Safety of 60 mg/kg body weight of Zemaira® weekly i.v. administration with Placebo weekly i.v... 2013-03-14 bad-data
Ongoing, reported early 2006-002068-25 A Single Site, Open-Label Study to Evaluate the Immunogenicity and Safety of Enzira in Healthy 'Adults' aged >18 to <60 years and in Healthy 'Older Adults' aged >60 years for the 2006/2007 Northern He... not-yet-due
Reported results 2006-004354-24 A Phase IV, Randomised, Observer-Blind,Comparator-Controlled, Single-Centre Study to Evaluate the Immunogenicity, Safety and Tolerability of CSL Influenza Vaccine (Enzira) (2006/2007) in Healthy Older... 2006-12-08 due-trials
Reported results 2006-006023-39 Pharmacokinetics of Haemocomplettan P in subjects with congenital fibrinogen deficiency 2008-05-15 due-trials
Listed as ongoing, but also has a completion date and reported results 2006-006522-25 A multicenter study on the efficacy and safety of Vivaglobin® in Previously Untreated Patients (PUPs) with Primary Immunodeficiency (PID) 2008-10-31 bad-data
Listed as ongoing, but also has a completion date and reported results 2006-006745-13 A multicenter study of the efficacy, tolerability, safety, and pharmacokinetics of Immune Globuline Subcutaneous (Human) IgPro20 in subjects with Primary Immunodeficiency (PID) 2009-08-31 bad-data
Ongoing, reported early 2007-000272-16 A Phase II, Double Blind, Randomised, Controlled, Multi-Centre Study to Evaluate the Immunogenicity, Safety and Tolerability of Three Formulations of CSL412 in Adults (≥ 18 to ≤ 45 years) and Older Ad... not-yet-due
Listed as ongoing, but also has a completion date and reported results 2007-000710-37 A multicentre study of subcutaneous immunoglobulin in patients with Multifocal Motor Neuropathy (MMN) 2009-01-05 bad-data
Reported results 2007-001465-14 A Single Centre, Open-Label Study to Evaluate the Immunogenicity and Safety of Enzira Vaccine in Healthy Adults aged ≥ 18 to < 60 years and in Healthy Older Adults aged ≥ 60 years for the 2007/2008 No... 2007-06-22 due-trials
Reported results 2007-004088-22 Efficacy and safety of Fibrinogen Concentrate (Human) for on-demand treatment of acute bleeding in subjects with congenital fibrinogen deficiency 2014-02-28 due-trials
Reported results 2007-004612-31 Efficacy and safety of Haemocomplettan® P in patients experiencing acute bleeding while undergoing aortic replacement surgery 2010-04-21 due-trials
Reported results 2007-007129-38 An open-label, non-controlled, multicenter, multinational Study to evaluate the Efficacy and Safety of Zemaira® administration in Chronic Augmentation and Maintenance Therapy in Subjects with Emphysem... 2015-09-18 due-trials
Completed, but no date, and reported results 2007-007861-19 An open-label, randomized, multicenter Phase IIIb study to assess the efficacy, safety and tolerance of BERIPLEX® P/N compared with plasma for rapid reversal of coagulopathy induced by coumarin deriva... bad-data
Reported results 2007-007862-39 An open-label, randomized, multicenter Phase IIIb study to assess the efficacy, safety and tolerance of Beriplex P/N compared with plasma for rapid reversal of coagulopathy induced by coumarin derivat... 2013-02-22 due-trials
Listed as ongoing, but also has a completion date and reported results 2008-000830-30 A Multicenter Extension Study of the Efficacy, Tolerability, and Safety of Immune Globulin Subcutaneous (Human) IgPro20 in Subjects with Primary Immunodeficiency (IgPro20 EU Extension Study) 2011-12-21 bad-data
Reported results 2008-001104-23 A Phase II, multicentre, double-blinded, randomised, cross-over study to evaluate efficacy, safety and pharmacokinetics of Biostate® in subjects with Haemophilia A. 2010-10-15 due-trials
Reported results 2008-001422-14 A Single Centre, Open-Label Study to Evaluate the Immunogenicity and Safety of Enzira® vaccine in Healthy ‘Adults’ aged ≥ 18 to < 60 years and in Healthy ‘Older Adults’ aged ≥ 60 years for the 2008/20... 2008-11-14 due-trials
Completed, but no date, and reported results 2008-004922-18 An Open-label, Multi-centre Study to Assess the Pharmacokinetics, Efficacy and Safety of Biostate® in Subjects with Von Willebrand Disease. bad-data
Reported results 2008-005324-93 A Single Centre, Open-Label Study to Evaluate the Immunogenicity and Safety of Enzira® vaccine in Healthy ‘Adults’ aged ≥ 18 to < 60 years and in Healthy ‘Older Adults’ aged ≥ 60 years for the 2008/20... 2008-10-19 due-trials
Ongoing, reported early 2009-010387-41 A 12-week, Multicenter, Pharmacokinetic and Safety Study of Human Plasma-Derived Factor XIII Concentrate in Subjects with Congential Factor XIII Deficiency not-yet-due
Reported results 2009-010722-19 A Prospective, Multicenter, Open-label, Phase 3b Study of Human Plasma-Derived Factor XIII Concentrate in Subjects with Congenital Factor XIII Deficiency 2011-06-16 due-trials
Reported results 2009-011450-18 A Phase IV, Single-centre, Open-label Study to Evaluate the Immunogenicity and Safety of the 2009/2010 Formulation of the Enzira® Vaccine in Two Groups of Healthy Volunteers: ‘Adults’ (aged ≥ 18 to < ... 2009-05-28 due-trials
Reported results 2009-015112-18 A Phase III, Open-Label, Multicentre Study to Evaluate Efficacy, Pharmacokinetics, and Safety of Biostate® in Paediatric Subjects with Haemophilia A. 2014-07-01 due-trials
Reported results 2009-017301-11 An Open-Label, Multi-Centre Extension Study to Assess the Efficacy and Safety of Biostate® in Paediatric, Adolescent, and Adult Subjects with Von Willebrand Disease who Completed Clinical Studies CSLC... 2014-03-28 due-trials
Reported results 2009-017672-24 A single-arm study to demonstrate the efficacy and safety of Privigen in the treatment of subjects with chronic inflammatory demyelinating polyneuropathy (CIDP) 2011-11-29 due-trials
Reported results 2009-017753-34 A Phase III Open-label, Multi-centre Study to Assess the Pharmacokinetics, Efficacy, and Safety of Biostate® in Paediatric Subjects with von Willebrand Disease. 2013-08-27 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-018477-38 An Open-label, Multicenter, Dose-escalation Safety and Pharmacokinetic Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein (rIX-FP) in subjects with Hemophilia B 2011-07-22 bad-data
Reported results 2010-019532-12 A Phase IV, Single-Centre, Open-label Study to Evaluate the Immunogenicity and Safety of the 2010/2011 Formulation of the Enzira® vaccine in Two Groups of Healthy Volunteers: ‘Adults’ (aged 18 to 59 y... 2011-05-27 due-trials
Listed as ongoing, but also has a completion date and reported results 2010-020113-85 A Multi-center, Interventional, Non-randomized, Open-label, Single-group Phase III Study to evaluate Plasma-Derived Antihemophilic Factor/von Willebrand Factor Concentrate (Biostate®) for Immune Tol... 2014-03-07 bad-data
Listed as ongoing, but also has a completion date and reported results 2010-024242-30 Prospective open-label uncontrolled multi-center post-marketing study to assess inhibitory antibody formation in subjects with congenital C1-INH deficiency and acute hereditary angioedema (HAE) attack... 2014-11-14 bad-data
Reported results 2011-000263-27 An open-label, prospective, multicenter study to investigate the specificity of in vivo antibody binding to red blood cells in subjects with chronic immune thrombocytopenic purpura (ITP) treated with ... 2014-09-17 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-002393-23 A Phase I/III Open-label, Multicenter, Crossover Safety, Efficacy and Pharmacokinetic Study of Recombinant Coagulation Factor VIII (rFVIII) Compared to Recombinant Factor VIII (rFVIII; INN: octocog al... 2015-01-30 bad-data
Reported results 2011-002415-28 A Phase II/III Open-label, Multicenter, Safety and Efficacy Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein (rIX-FP) in Subjects with Hemophilia B 2014-07-21 due-trials
Listed as ongoing, but also has a completion date and reported results 2011-002685-20 REPLACE (Randomized evaluation of fibrinogen versus placebo in complex cardiovascular surgery): a prospective, multinational, multicenter, randomized, double-blind, placebo-controlled, phase III study... 2014-09-14 bad-data
Listed as ongoing, but also has a completion date and reported results 2011-003448-28 Randomized, multicenter, double-blind, placebo-controlled, parallel-group phase III study to investigate the efficacy, safety, and tolerability of 2 different doses of IgPro20 (subcutaneous immunoglob... 2016-09-20 bad-data
Reported results 2011-006032-23 A Phase III Open-label, Multicenter, Pharmacokinetics, Safety, and Efficacy Study of a Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Children wit... 2014-10-05 due-trials
Reported results 2012-001101-24 A Phase IV, Single-Centre, Open-label Study to Evaluate the Immunogenicity and Safety of the 2012/2013 Formulation of the Enzira® vaccine in Two Groups of Healthy Volunteers: ‘Adults’ (aged 18 to 59 y... 2012-06-01 due-trials
Completed, report not yet due 2012-001309-26 A multicenter, open-label, multiple-dose, dose escalation study to investigate the pharmacokinetics, efficacy, and safety of rVIIa-FP (CSL689) in subjects with hemophilia (A or B) and inhibitors. 2018-04-05 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2012-001336-65 A Phase III Open-label Pharmacokinetic, Efficacy and Safety Study of rVIII-SingleChain in a Pediatric Population with Severe Hemophilia A 2015-08-24 bad-data
Ongoing 2012-005489-37 A Phase 3b Open-label, Multicenter, Safety and Efficacy Extension Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein (rIX-FP) in Subjects with Hemophilia B not-yet-due
Reported results 2013-000916-10 A double-blind, randomized, placebo-controlled, cross-over study to evaluate the clinical efficacy and safety of subcutaneous administration of human plasma-derived C1-esterase inhibitor in the prophy... 2015-10-15 due-trials
Ongoing 2013-003262-13 A Phase III Open Label, Multicenter, Extension Study to Assess the Safety and Efficacy of Recombinant Coagulation Factor VIII (rVIII-SingleChain, CSL627) in Subjects with Severe Hemophilia A not-yet-due
Listed as ongoing, but also has a completion date 2013-003305-25 An Open-label, Multi-centre Post-marketing Study to Assess the Efficacy and Safety of Voncento® in Subjects with Von Willebrand Disease 2018-02-15 bad-data
Listed as ongoing, but also has a completion date and reported results 2013-003458-26 A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects with Acute Myocardial Infa... 2016-03-21 bad-data
Completed, reported early 2013-004157-24 Multicenter, open-label extension study to investigate the 2017-07-10 not-yet-due
Listed as ongoing, but also has a completion date and reported results 2014-001054-42 An open-label, randomized study to evaluate the long-term clinical safety and efficacy of subcutaneous administration of human plasma-derived C1-esterase inhibitor in the prophylactic treatment of her... 2017-09-21 bad-data
No trial status on register 2014-003409-13 A Multicenter Study of Long-Term Clinical Outcomes of Immune Globulin Subcutaneous (Human) (SCIG) IgPro20 in Subjects with Primary Immunodeficiency bad-data
No trial status on register 2014-003605-15 A Multicenter Extension Study of the Efficacy, Tolerability, and Safety of Immune Globulin Subcutaneous (Human) IgPro20 in Subjects With Primary Immunodeficiency (PID) bad-data
No trial status on register 2014-003607-30 A Phase III Open-Label, Prospective, Multicenter Study of the Efficacy, Tolerability, Safety, and Pharmacokinetics of Immune Globulin Subcutaneous (Human), IgPro20 in Subjects With Primary Immunodefic... bad-data
No trial status on register 2014-003608-61 A Multicenter Study of Efficacy, Safety, Tolerability, and Pharmacokinetics of Immune Globulin Subcutaneous (Human) IgPro20 in Subjects With Primary Immunodeficiency bad-data
No trial status on register 2014-003609-14 A Multicenter Follow-up Study of Long-term Safety, Tolerability, and Efficacy of Immune Globulin Subcutaneous (Human) IgPro20 in Subjects With Primary Immunodeficiency bad-data
No trial status on register 2014-003764-20 A Prospective, Multicenter, Open Enrollment Study of Human Plasma-Derived Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency bad-data
No trial status on register 2014-003768-19 A Phase III, Randomized, Observer-blind, Multi-center, Noninferiority Comparison of the Immune Response of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Trivalent Inactivated Split-V... bad-data
No trial status on register 2014-003772-23 A Multicenter Extension Study on the Safety and Efficacy of IgPro10 in Patients With Primary Immunodeficiency (PID) bad-data
No trial status on register 2014-004131-40 A Phase IV, Open Label, Multi-Centre Study to Evaluate the Safety and Tolerability of CSL Limited's Influenza Virus Vaccine in a paediatric population aged greater than or equal to 6 months to less th... bad-data
No trial status on register 2014-005183-15 A Phase II, Multicentre, Randomised, Observer-blind Study to Evaluate the Immunogenicity, Safety and Tolerability of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Children Aged >= 6 Months to ... bad-data
No trial status on register 2014-005401-20 An Open-label, Multi-centre Study to Assess the Efficacy and Safety of Biostate® in Patients With von Willebrand's Disease (VWD) bad-data
No trial status on register 2015-000176-10 A Phase II, Multicenter, Randomized, Observer-blind, Placebo-controlled Study to Evaluate the Immunogenicity, Safety and Tolerability of CSL’s 2009 H1N1 Influenza Vaccine (CSL425) in a Healthy Pediatr... bad-data
No trial status on register 2015-000177-12 An Observer-Blind, Randomized, Comparator-Controlled, Single-Centre Study to Evaluate the Tolerability, Safety, and Immunogenicity of Inactivated Influenza Vaccine, CSL Limited in a Healthy Pediatrics... bad-data
Reported results 2015-003017-26 A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects with Modera... 2017-06-28 due-trials
No trial status on register 2015-004820-69 An Open-Label, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of CSL's Influenza Vaccine in a Paediatric Population (= or >6 Months to < 9 Years of Age). bad-data
No trial status on register 2015-004977-34 Study of immune deficiency patients treated with subcutaneous immunoglobulin (IgPro20, Hizentra®) on weekly and biweekly schedules bad-data
No trial status on register 2016-001631-12 Prospective open-label single-arm study of the pharmacokinetics and safety of intravenous IgPro10 in Japanese subjects with primary immunodeficiency bad-data
Ongoing 2016-002510-50 A low-interventional Multicentre Post-Authorisation Safety Study for Voncento/Biostate/Aleviate for Routine Prophylaxis, Treatment of Bleeding Events and/or Surgery in Male Subjects with Haemophilia A not-yet-due
No trial status on register 2016-003798-16 Comparison of 2 Infusion Devices with Respect to Pharmacokinetics, Safety, and Tolerability of Hizentra®: Investigational Wearable Infusor and the Crono S-PID-50 Infusion Pump bad-data
No trial status on register 2016-003799-33 An open-label multicenter study to evaluate the safety and tolerability of higher infusion parameters of immune globulin subcutaneous (human), 20% liquid (Hizentra®) in subjects with primary immunodef... bad-data
Ongoing 2017-000348-17 A double-blind, randomized-withdrawal, placebo-controlled study to evaluate the efficacy and safety of human plasma-derived C1-esterase inhibitor as add-on to standard of care for the treatment of ref... not-yet-due
Ongoing 2017-000996-98 A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome not-yet-due